What's New

The objectives of the survey were to collect data which can be used to track the HIV epidemic among FSW and guide the response in terms of providing prevention, care and treatment services for this population. Key measures of the survey included HIV seroprevalence, key risk behavior data, service utilization, experience with stigma and discrimination, and estimates of population size. The eligibility criteria for the survey were women aged 15-49 years old, currently living or working in the survey city, and who sold sex for cash or kind in the last 12 months.

The objectives of the survey were to track the epidemic using behavioral risk, experience with stigma and discrimination and HIV seroprevalence markers and assess the progress of the response in terms of utilization of prevention, care and treatment services.

This report presents the results of the 2017-18 Integrated Biological and Behavioural Survey (IBBS), among people who inject drugs (PWID) in selected sites in Myanmar, including a formative assessment and population size estimations. A formative assessment was conducted in September 2017 in each site to inform the implementation of the IBBS. The assessment was conducted to assess the particulars of PWID populations in each setting, to provide information to tailor RDS and PSE methods and logistic approaches to the different PWID population and epidemic context.  

This resource presents 16 Minimum Standards for the prevention of and response to gender-based violence in emergencies. As a whole, the 16 Minimum Standards define what agencies working on specialized gender-based violence programming need to achieve to prevent and respond to gender-based violence, and deliver multisectoral services. The objective of the Minimum Standards is to establish a common understanding of what constitutes minimum prevention and response programming in emergencies.

Sexual and reproductive health and rights (SRHR) are essential for reaching the Sustainable Development Goals (SDGs) for health. The Guttmacher-Lancet Commission found that meeting the unmet need for contraception for 214 million women in developing regions would avert an additional 67 million unintended pregnancies in 2017. If combined with full care for pregnant women and newborns, this reduction in unplanned pregnancies would reduce maternal deaths by 73% (from 308,000 to 84,000) and newborn deaths by 80% (from 2.7 million to about 538,000).

Recognizing that the promotion and protection of the human rights of people affected by tuberculosis is a legal, ethical and moral imperative, as well as of crucial importance for the effectiveness of the response to the epidemic and the relief of suffering among affected individuals and communitie.

TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2018 and analyzes trends in funding since 2005. The report—Tuberculosis Research Funding Trends, 2005–2018—is a critical accountability tool and serves as a barometer of progress in raising support for the scientific innovation needed to eliminate TB.

Key informant semi-structured interview and focus group discussion guides.

Tuberculosis (TB) is curable but it still kills more people globally than any other single infectious disease. This is mainly due to challenges in accessing quality, affordable and equitable TB services and care. Millions of people affected by TB endure its hardships and manage to survive despite these barriers, which are driven by and heightened by TB stigma. Put simply, to end TB, we must end TB stigma.

The goal of the Global Plan is to provide a costed blueprint for actions that countries should take to fulfil the targets and commitments in the Political Declaration of the UNHLM on TB and to get on track to end TB as outlined in the WHO’s End TB Strategy and the SDGs.